Inotek Pharmaceuticals Corporation announced today the addition of two new members to its Board of Directors: Michael Loberg, Ph.D. and Mitchell Fink, M.D. Dr. Loberg is currently the President and CEO of NitroMed. Dr. Loberg’s career spans more than 25 years in the pharmaceutical industry, including almost 12 years of direct involvement in drug discovery and development, notably in leadership roles in senior management and executive positions at the Bristol-Myers Squibb Company. Dr. Fink, the Watson Professor of Surgery at the University of Pittsburgh, is the founding Chairman of the Department of Critical Care Medicine at the University of Pittsburgh School of Medicine, former President of the Shock Society, and an internationally renowned expert in the field of critical care medicine.
